Skip to main content
Clinical Trials/JPRN-UMIN000018780
JPRN-UMIN000018780
Completed
未知

The multicenter study for purposes of detection of prognostic factor of advanced stage pediatric lymphoblastic lymphoma treated with standard chemotherapy - The multicenter to detect prognostic factor of advanced stage pediatric lymphoblastic lymphoma treated with standard chemotherapy (ALB-NHL-14)

Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)0 sites92 target enrollmentSeptember 1, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
lymphoblastic lymphoma stage III / IV
Sponsor
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
Enrollment
92
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2015
End Date
August 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Down syndrome. (2\) Other previous illness of malignant tumor or previous therapy of organ transplantation including hematopoietc stem cells. (3\) history of congenital or acquired immunodeficiency. (4\) uncontrolled infection, including active tuberculosis infection and positive of HIV antibody. (5\) pregnancy or high possibility of pregnancy and giving suck woman. (6\) QTfc, corrected by Friderics formula as QTfc \= QT/RR\*1/3, is more than 0\.45 seconds. (7\) CNS hemorrage more than grade 3 of CACAE v4\.0 (8\) MDS, Ph1 positive (9\) any inappropriate status judged by physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials